Cambridge Investment Research Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
3,225
+1,043
| +48% | +$327K | ﹤0.01% | 1937 |
|
|
2025
Q1 | $665K | Sell |
2,182
-563
| -21% | -$172K | ﹤0.01% | 2188 |
|
|
2024
Q4 | $912K | Sell |
2,745
-380
| -12% | -$126K | ﹤0.01% | 1949 |
|
|
2024
Q3 | $1.04M | Sell |
3,125
-105
| -3% | -$35K | ﹤0.01% | 1831 |
|
|
2024
Q2 | $1.33M | Sell |
3,230
-3
| -0.1% | -$1.24K | ﹤0.01% | 1575 |
|
|
2024
Q1 | $1.31M | Sell |
3,233
-245
| -7% | -$99K | 0.01% | 1550 |
|
|
2023
Q4 | $1.07M | Sell |
3,478
-277
| -7% | -$84.9K | ﹤0.01% | 1610 |
|
|
2023
Q3 | $909K | Buy |
3,755
+440
| +13% | +$107K | ﹤0.01% | 1642 |
|
|
2023
Q2 | $796K | Sell |
3,315
-1,276
| -28% | -$306K | ﹤0.01% | 1774 |
|
|
2023
Q1 | $863K | Buy |
4,591
+1,472
| +47% | +$277K | ﹤0.01% | 1671 |
|
|
2022
Q4 | $663K | Buy |
3,119
+1,452
| +87% | +$309K | ﹤0.01% | 1806 |
|
|
2022
Q3 | $262K | Buy |
1,667
+119
| +8% | +$18.7K | ﹤0.01% | 2477 |
|
|
2022
Q2 | $232K | Sell |
1,548
-33
| -2% | -$4.95K | ﹤0.01% | 2591 |
|
|
2022
Q1 | $259K | Buy |
1,581
+349
| +28% | +$57.2K | ﹤0.01% | 2665 |
|
|
2021
Q4 | $268K | Sell |
1,232
-436
| -26% | -$94.8K | ﹤0.01% | 2637 |
|
|
2021
Q3 | $316K | Buy |
+1,668
| New | +$316K | ﹤0.01% | 2416 |
|